Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hans U. Schlicker"'
Autor:
Theo F. J. Kraus, Johannes Pöppe, Lukas Machegger, Barbara Zellinger, Eva Dovjak, Hans U. Schlicker, Christoph Schwartz, Barbara Ladisich, Mathias Spendel, Abdul R. Al‐Schameri, Peter A. Winkler, Karl Sotlar
Publikováno v:
Clinical Case Reports, Vol 9, Iss 9, Pp n/a-n/a (2021)
Abstract This case of severe phenotype‐genotype mismatch brain tumor morphologically mimicking benign ganglioglioma emphasizes the urgent need for advanced molecular profiling in brain tumor diagnosis in the era of sophisticated molecular profiling
Externí odkaz:
https://doaj.org/article/e5617cc96d5d4680875d7f2718013b79
Autor:
Dorothee Hölzl, Georg Hutarew, Barbara Zellinger, Beate Alinger-Scharinger, Hans U. Schlicker, Christoph Schwartz, Karl Sotlar, Theo F. J. Kraus
Publikováno v:
Biomedicines, Vol 10, Iss 4, p 794 (2022)
Gliomas are the most common intrinsic brain tumors in adults, and in accordance with their clinical behavior and patients’ outcome, they are graded by the World Health Organization (WHO) classification of brain tumors. One very interesting candidat
Externí odkaz:
https://doaj.org/article/64a59b7e618746528fb3a4a8e5ecf115
Autor:
Sotlar, Theo F. J. Kraus, Celina K. Langwieder, Dorothee Hölzl, Georg Hutarew, Hans U. Schlicker, Beate Alinger-Scharinger, Christoph Schwartz, Karl
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3525
Glioblastoma IDH wildtype is the most frequent brain tumor in adults. It shows a highly malignant behavior and devastating outcomes. To date, there is still no targeted therapy available; thus, patients’ median survival is limited to 12–15 months
Autor:
Theo F. J. Kraus, Christoph Schwartz, Lukas Machegger, Barbara Zellinger, Dorothee Hölzl, Hans U. Schlicker, Johannes Pöppe, Barbara Ladisich, Mathias Spendel, Michael Kral, Karl Sotlar
Publikováno v:
Brain Tumor Pathology. 39:111-119
Here, we report on a patient presenting with two histopathologically distinct gliomas. At the age of 42, the patient underwent initial resection of a right temporal oligodendroglioma IDH mutated 1p/19q co-deleted WHO Grade II followed by adjuvant rad
Autor:
Georg Hutarew, Dorothee Hölzl, Tanja Schiefer, Celina K. Langwieder, Beate Alinger-Scharinger, Hans U. Schlicker, Christoph Schwartz, Karl Sotlar, Theo F. J. Kraus
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5375
Glioblastomas are the most frequent primary brain tumors in adults. They show highly malignant behavior and devastating outcomes. Since there are still no targeted therapies available, median survival remains in the range of 12 to 15 months for gliob
Autor:
Georg Hutarew, Barbara Zellinger, Peter A Winkler, Dorothee Hölzl, Hans U Schlicker, Karl Sotlar, Theo Kraus, Christoph Schwartz
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Gliomas are the most frequent primary brain tumors of adults. Despite intensive research, there are still no targeted therapies available. Here, we performed an integrated analysis of glioma and programmed cell death ligand 1 (PD-L1) in 90 sa
Autor:
Johannes Pöppe, Christoph Schwartz, Michael Kral, Barbara Zellinger, Mathias Spendel, Peter A Winkler, Barbara Ladisich, Theo Kraus, Annekathrin Reinhardt, Lukas Machegger, Karl Sotlar, Eva Dovjak, Hans U Schlicker
Publikováno v:
Brain Tumor Pathology
Here, we report on a 28-year old male patient presenting with neck and shoulder pain, dysesthesia of all four limbs and hypesthesia of both hands, without motor deficits. Magnetic resonance imaging showed an intradural, intramedullary mass of the cer
Autor:
Lukas Machegger, Barbara Ladisich, Eva Dovjak, Abdul Rahman Al-Schameri, Johannes Pöppe, Hans U Schlicker, Mathias Spendel, Barbara Zellinger, Karl Sotlar, Christoph Schwartz, Theo Kraus, Peter A Winkler
Publikováno v:
Clinical Case Reports, Vol 9, Iss 9, Pp n/a-n/a (2021)
Clinical Case Reports
Clinical Case Reports
This case of severe phenotype‐genotype mismatch brain tumor morphologically mimicking benign ganglioglioma emphasizes the urgent need for advanced molecular profiling in brain tumor diagnosis in the era of sophisticated molecular profiling.
Th
Th